INDIANAPOLIS, Oct. 12, 2016 /PRNewswire/ -- Supported by
Eli Lilly and Company (NYSE: LLY), the Arthritis Foundation is
launching 'Living Your Yes With RA,' a new initiative designed to
empower people living with rheumatoid arthritis (RA) by giving them
tools, education and resources, allowing them to expect more from
their RA treatment – seeking remission or low disease activity as
the only acceptable outcome. The program will be implemented in 15
cities across the U.S.
"The Arthritis Foundation is committed to providing access to
information and optimum care to the rheumatoid arthritis
community," said Cindy McDaniel,
senior vice president, consumer health and impact, Arthritis
Foundation. "We understand the difficulties RA brings, including
joint pain, swelling, stiffness and fatigue, and want to help
patients to start saying 'Yes' despite the challenges they face
living with this disease. The Arthritis Foundation is focused on
providing patients with the tools they need to set and track
treatment goals, communicate more effectively with their health
care providers about their goals and live a full life."
The Arthritis Foundation will host free 'Living Your Yes With
RA' goal-setting events, facilitated by local rheumatologists, over
a three year period. Rheumatologists will highlight available tools
and resources for setting and tracking goals so patients can strive
to reach low-disease activity or remission. They will also provide
training for implementing the tools and tips on the best ways for
patients to discuss their goals with their doctor.
"We are proud to support the Arthritis Foundation in this
exciting new program," said John R.
Richards, director of global advocacy and professional
relations, Lilly. "We support initiatives like 'Living Your Yes
With RA' as they provide important education for patients and
health care providers and the need to consider both clinical and
life goals as indicators of treatment success."
Beginning this fall, the Arthritis Foundation will host 'Living
Your Yes With RA' events in 15 cities including Tampa, St. Louis,
Chicago, Houston, Indianapolis, Phoenix, Cleveland, Boston,
Atlanta, Washington, DC, Minneapolis, Charlotte, Los Angeles,
Philadelphia and Dallas. For more information on events in your
state, please visit your local chapter's website.
Resources and downloadable tools are available by visiting
www.arthritis.org/toolkits/better-living/.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with
discovery to make life better for people around the world. We were
founded more than a century ago by a man committed to creating
high-quality medicines that meet real needs, and today we remain
true to that mission in all our work. Across the globe, Lilly
employees work to discover and bring life-changing medicines to
those who need them, improve the understanding and management of
disease, and give back to communities through philanthropy and
volunteerism. To learn more about Lilly, please visit us
at www.lilly.com and newsroom.lilly.com/social-channels.
About the Arthritis Foundation
The Arthritis
Foundation is the Champion of Yes. Leading the fight for the
arthritis community, the Foundation helps conquer everyday battles
through life-changing information and resources, access to optimal
care, advancements in science and community connections. The
Arthritis Foundation's goal is to chart a winning course, guiding
families in developing personalized plans for living a full life –
and making each day another stride towards a cure. The Foundation
also publishes Arthritis Today, the award-winning magazine that
reaches 4 million readers per issue.
About Rheumatoid Arthritis
Rheumatoid arthritis is an
autoimmune disease characterized by inflammation and progressive
destruction of joints.[i,ii] Approximately three times
as many women as men have the disease. Current treatment of RA
includes the use of non-steroidal anti-inflammatory drugs, oral
conventional disease-modifying antirheumatic drugs (cDMARDs), such
as methotrexate – the current standard of care – and injectable,
biological disease-modifying antirheumatic drugs (bDMARDs) that
target selected mediators implicated in the pathogenesis of
RA.[iii] Despite current treatment options, many
patients do not reach their therapeutic goals or sustained
remission.[iv,v] There remains an important need to
provide additional treatments to improve overall patient care.
CR-LLY
i American College of Rheumatology, Rheumatoid
Arthritis,
http://www.rheumatology.org/practice/clinical/patients/diseases_and_conditions/ra.asp (Accessed: October
11 2016)
ii Hand Clinics, Advances in the Medical
Treatment of Rheumatoid Arthritis,
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135413/pdf/nihms305780.pdf (Accessed:
October 11, 2016)
iii Arthritis Foundation, Medications for
Rheumatoid
Arthritis, http://www.arthritistoday.org/about-arthritis/types-of-arthritis/rheumatoid-arthritis/treatment-plan/medication-overview/ra-medications.php (Accessed: October
11, 2016)
iv Rheumatoid arthritis, Lancet,
https://www.ncbi.nlm.nih.gov/pubmed/27156434 (Accessed:
October 11, 2016)
v Sustained rheumatoid arthritis remission is uncommon
in clinical practice, Arthritis Research & Therapy,
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446437/ (Accessed:
October 11, 2016)
Refer to: Nicholas
Turkas; nturkas@arthritis.org; +1-704-705-1801 (Arthritis
Foundation media)
Heidi Pio; hpio@arthritis.org;
+1-309-863-3506 (Arthritis Foundation media)
Nan Frient; frient_nan@lilly.com;
+1-317-471-7040 (Lilly media)
Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/eli-lilly-and-company-sponsors-arthritis-foundation-living-your-yes-with-ra-an-initiative-to-provide-resources-for-the-rheumatoid-arthritis-community-300343146.html
SOURCE Eli Lilly and Company